Greg Gottesman

Greg Gottesman is a Managing Director at Madrona Venture Group, investing in early stage companies. He loves investing in and building early stage companies. Greg currently serves on the boards of BuddyTV, Cheezburger, Decide.com, ThisLife, WildTangent, Startup Weekend, and a number of others. He was the founder and serves on the board of Rover.com. Greg blogs at StarkRavingVC.com.

Recent posts

Time Kills All Deals
On a long enough timeline, the survival rate for everyone drops to zero.
—Narrator, Fight Club
No matter how compelling your product or service is, no matter how great the... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
IBM Watson Health Data in Action – Epidemiology Studies
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More

F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections

Seres Sets Sights on FDA After C. Diff Microbiome Therapy Scores in Phase 3

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

With FDA Nod, NS Pharma Duchenne Drug Becomes Sarepta Competitor

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

G1 Vets Launch Arc Therapeutics to Take on New Cancer Target

Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup

Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

Telehealth Firm AristaMD Adds $24M to Link Primary Docs With Specialists

Two Days, Six IPOs, and $1B Raised for Biotech Research & More

Omega Therapeutics Lands $85M to Tap Into “Control Room” of Biology

The Xcelerate Keynote Series – Part of Biotech Week Boston

The 2020 National Xconomy Awards

Xcelerating Life Sciences Seattle

Xcelerating Life Sciences New York

Greg Gottesman

Recent posts

Time Kills All Deals

Underwriters and Partners

IBM Watson Health Data in Action – Epidemiology Studies

What’s Next in Neuroscience Therapies

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

Xconomy on Demand

We offer a number of ways to subscribe for free!